Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (5): 313-314.
Previous Articles Next Articles
CAO Jianying1, QU Xiujun1, QIN Ying2, SHI Zhongge1, ZHANG Anchao1, LI Zhongliang3,*
Received:2019-03-16
Revised:2019-06-11
Online:2019-05-20
Published:2019-06-11
CLC Number:
CAO Jianying, QU Xiujun, QIN Ying, SHI Zhongge, ZHANG Anchao, LI Zhongliang. Two Cases of Neonatal Hypocalcemia Induced by Sodium Phosphate for Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(5): 313-314.
| [1] 林万龙,陈瑶,杨剑辉.儿童辅助治疗药物磷酸肌酸钠专项点评前后合理性比较[J].中国医院药学杂志,2017.37(5):478-481. [2] 《中国国家处方集》编委会.《中国国家处方集》(化学药品与生物制品卷·儿童版)[M].人民军医出版社,2013:213. [3] 邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M]. 4版.人民卫生出版社..2018:562-563. [4] 李凤敏,戴军,陈玉霞,等.兰州市小于18岁健康儿童心肌酶谱参考值趋势性分析[J].实用儿科临床杂志,2011,26(13):1022-1024. [5] 邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M]. 4版.人民卫生出版社,2018:763-764. [6] 焦颖,马建荣,刘巍巍.磷酸肌酸钠静脉用药引起新生儿低钙血症的临床分析[J].中国临床药学杂志,2016,25(6):370-373. [7] 章樱,陈国庆,张勤.磷酸肌酸钠对新生儿缺氧缺血性脑病氧化应激的影响及心肌损伤的保护作用[J].中华全科医学,2016.14(5):786-789. [8] 张彤,磷酸肌酸钠对新生儿心肌损伤的疗效观察[J].医学综述,2012,18(22):3872-3874. [9] 缪珀,孙斌,冯星.磷酸肌酸钠治疗新生儿窒息后心肌损伤的meta分析[J].中国当代儿科杂志,2012,14(3):172-176. [10] Kraft M D.Phosphorus and calcium: a review for the adult nutrition support clinician[J].Nutr Clin Pract,2015,30(1):21-33. [11] Konan D J,Amon-Tanoh-Dick F, Aka J,et al. Determinants of neonatal serem calcium in a peripheral maternity in Abidjian[J].Pan Afr Med,2015,21(20):390. [12] 吉林英联生物制药股份有限公司.杜玛注射用磷酸肌酸钠[EB/OL].(2013-02-04) [2019-04-17].http://www.jlylsw.com/ebook/e1/ . [13] Levy-Shraga Y,Dallalzadeh K,Stem K,et al.The many etiologies of neonatal hypocalcemic seizures[J].Pediatr Emerg Care,2015,31(3):197. [14] 王丹. 药物不良反应主动监测及其发展趋势[J].中国药物警戒. 2015,12(10):600-602. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
